Short Interest in Genscript Biotech Co. (OTCMKTS:GNNSF) Decreases By 6.0%

Genscript Biotech Co. (OTCMKTS:GNNSF) saw a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 6,386,400 shares, a drop of 6.0% from the September 15th total of 6,791,800 shares. Based on an average daily trading volume, of 1,800 shares, the short-interest ratio is currently 3,548.0 days.

Genscript Biotech Stock Performance

Genscript Biotech stock opened at C$1.40 on Friday. Genscript Biotech has a 12 month low of C$1.05 and a 12 month high of C$3.20. The company’s fifty day simple moving average is C$1.47 and its 200-day simple moving average is C$1.44.

About Genscript Biotech

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.